Tareno Schweizer Aktien­perlen Fonds

In our new “Invest­ment Insight” series, we present exciting and current invest­ment oppor­tu­ni­ties to our readers. The first issue is all about our Tareno Schweizer Aktien­perlen Fonds. Find out how the fund is struc­tured and what develo­p­ments it has under­gone since its launch in May 2023.

What a start to the year! With a perfor­mance of 8% in January, our Schweizer Aktien­perlen Fund has made a brilliant start to the year, conti­nuing its very pleasing perfor­mance since its launch. Since May 2023, the fund has outper­formed the Swiss equity market by 7.2%. To get to the bottom of Tareno’s recipe for success, we asked Frank Pfeiffer, the lead fund manager, about the special features of the Schweizer Aktien­perlen Fonds   .

Cumula­tive return since fund launch as at 31.01.2025

Source: Tareno Asset Management / Bloomberg

Hint: Fund launch May 22, 2023 Past performance is not indicative of future results.

What strategy does the Tareno Schweizer Aktien­perlen Fonds pursue?

The fund invests exclu­si­vely in compa­nies domic­iled in Switz­er­land. The focus is on large caps with sustainable dividend payouts, while selected mid caps are included in the portfolio accor­ding to strict selec­tion criteria in terms of finan­cial stabi­lity, funda­mental valua­tion, growth poten­tial and liqui­dity. With a targeted selec­tion of at least 30 compa­nies from various sectors, the oppor­tu­ni­ties of the Swiss equity market can be optimally exploited without sacri­fi­cing broad diver­si­fi­ca­tion. To avoid cluster risks, the weighting of indivi­dual positions is limited to a maximum of 5%.

Why should investors invest in Swiss equities?

Swiss compa­nies impress with their stabi­lity and innova­tive strength. Switz­er­land’s excep­tional legal certainty and reliable regula­tory environ­ment play a decisive role in this. Due to the limited domestic market, many Swiss compa­nies have successfully held their own in global compe­ti­tion for decades and thus benefit from inter­na­tional growth oppor­tu­ni­ties. The strong Swiss franc has always forced Swiss compa­nies to diffe­ren­tiate themselves through quality and innova­tion – two core values that make compa­nies successful in the long term.

For which investors is the fund suitable?

The fund is suitable for all investors who want to benefit from the advan­tages of the Swiss equity market in an uncom­pli­cated way. With a histo­rical annual return on the Swiss equity market of 7.7% per year in the period from 1926 to 2024 and a current dividend yield of 2.2%, an invest­ment is parti­cu­larly suitable for long-term wealth accumu­la­tion, for example for retire­ment provi­sion.

How does the fund differ from other Swiss equity funds?

Compared to passive index products, the fund offers the oppor­tu­nity for additional returns and better risk diver­si­fi­ca­tion. Since its launch in May 2023, our quali­ta­tive selec­tion has proven its strength and achieved a signi­fi­cant outper­for­mance compared to index products. We signi­fi­cantly reduce cluster risk through broad diver­si­fi­ca­tion and by limiting the position size to a maximum of 5%. In compa­rison, around 53% and 42% of the weighting in the Swiss market and Swiss perfor­mance index respec­tively is concen­trated on the three largest compa­nies Nestlé, Novartis and Roche. The fund is also charac­te­rized by an attrac­tive fee struc­ture of around 0.7% total costs p.a., which is extre­mely compe­ti­tive for an actively managed fund in Switz­er­land.

Portrait Frank Pfeiffer

Do you have any questions about the fund?

Would you like to find out more about our Tareno Schweizer Aktien­perlen Fonds or do you have any questions about the contri­bu­tion? Our Lead Fund Manager Frank Pfeiffer will be happy to answer your questions and provide explana­tions.

Learn more about us

Tareno Fund

Publi­ca­tions

Publisher: Tareno AG, Garten­strasse 56, 4052 Basel, Tel. +41 61 282 28 00, info@​tareno.​ch, www.tareno.ch. We welcome feedback on our publi­ca­tion. This content is for infor­ma­tion purposes only. The publi­ca­tion contains neither legal nor invest­ment advice or invest­ment recom­men­da­tions and does not consti­tute an offer or solici­ta­tion to make an invest­ment.